출판 : MarketsandMarkets (마켓츠앤마켓츠) 출판년월 : 2023년06월
의료 시장의 디지털 트윈 (Digital Twins in Healthcare) : 구성 요소(소프트웨어, 서비스), 용도(맞춤형 의학, 신약 개발, 의학 교육, 워크플로 최적화), 최종 사용자(의료 제공자, 연구 기관, 학술 기관, 지불자), 지역별 – 2028년까지의 세계 예측
Digital Twins in Healthcare Market by Component (Software, Services), Application (Personalized Medicine, Drug Discovery, Medical Education, Workflow Optimization), End User (Providers, Research & Academia, Payers), and Region – Global Forecast to 2028
| 페이지수 | 208 |
| 도표수 | 155 |
| 구성 | 영문조사보고서 |
| 가격 |
The global digital twin healthcare market is projected to reach USD 21.1 billion by 2028 from USD 1.6 billion in 2023, at a high CAGR of 67.0% during the forecast period. The technological advancements in digital twins supporting various healthcare applications and the growing adoption of digital twin technology in emerging markets will provide lucrative opportunities to the market during the forecast period.
“Personalized medicine segment accounted for a substantial share of the digital twins in healthcare market, by Application in 2022.”
In 2022, the personalized medicine segment accounted for a substantial share of the digital twins in healthcare market. The growth of this segment is attributed to its ability to improved patient modeling, minimized risk factors, and enhanced patient outcomes, making it a highly prominent application in the healthcare industry. Personalized medicine also offers an undistinguished advantage of tailoring treatments to individual patients based on their unique characteristics and hence optimizing therapeutic interventions, increasing the likelihood of successful outcomes.
“Healthcare Providers segment accounted for a considerable share in the digital twins in healthcare market, by end user in 2022”
In 2022, the healthcare providers segment accounted for a significant share of the digital twins in healthcare market. The healthcare provider segment dominates the digital twin healthcare market due to its vital role in workflow management and surgical planning. Digital twins also offers various additional advantages such as accurate patient modeling, personalized treatment planning, and monitoring, leading to improved clinical decision-making and patient outcomes.
“Asia Pacific to witness the substantial growth rate during the forecast period.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Factors such as growing demand for advanced technologies such as increased adoption of technologies such as IoT, telemedicine, government initiatives, digital twin for research & genomics purposes, growing awareness and adoption of digital twin in emerging regions, growing medical tourism, and improving healthcare infrastructure.
The break-down of primary participants is as mentioned below:
• By Company Type – Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
• By Designation – C-level: 42%, Director-level: 31%, and Others: 27%
• By Region – North America: 32%, Europe: 32%, Asia Pacific: 26%, Rest of the World: 10%
Key Players in the Digital twins in the Healthcare Market
The key players operating in the digital twin in healthcare market include Siemens Healthineers AG (Germany), Dassault Systèmes (France), Microsoft (US), Koninklijke Philips N.V. (Netherlands), Faststream Technologies (US), Twin LTD (US), IBM (US), NVIDIA Corporation (US), GE Healthcare (US), NUREA (France), ANSYS, Inc. (US), Rescale, Inc. (US), Predictiv (US), Verto Health (Canada), PrediSurge (France), Qbio (US), Virtonomy GmbH (Germany), Unlearn AI (US), Atos SE (France), ThoughtWire (Canada), Amazon Web Services, Inc.(US), Oracle(US), PTC (US), SAP (Germany), Sim and Cure (France).
Research Coverage:
The report analyzes the Digital Twins in Healthcare Market and aims to estimate the market size and future growth potential of various market segments, based on components, application, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
Analysis of key drivers (increasing Investments in digital twins in developed as well as emerging technology adoption, rising demand for personalized medicine, increasing funding and investments in digital twin startups), restraints (accuracy and privacy issues with digital twin systems and high implementation costs), opportunities (growing importance of digital twin Iin emerging market, increasing focus on cutting edge real-time data analytics), and challenges (lack of technical expertise & data management issues) influencing the growth of the digital twin market.
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the digital twins in healthcare market.
Market Development: Comprehensive information on the lucrative emerging markets, component, application, end-user, and region.
Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the digital twins in healthcare market
Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the digital twins in healthcare market like Siemens Healthineers AG (Germany), Dassault Systèmes (France), Microsoft (US), Koninklijke Philips N.V. (Netherlands), Faststream Technologies (US), IBM (US), NVIDIA Corporation (US), GE Healthcare (US).
목차
1 INTRODUCTION 24
1.1 STUDY OBJECTIVES 24
1.2 MARKET DEFINITION 24
TABLE 1 INCLUSIONS & EXCLUSIONS 24
1.3 STUDY SCOPE 25
FIGURE 1 DIGITAL TWINS IN HEALTHCARE MARKET SEGMENTATION 25
1.3.1 DIGITAL TWINS IN HEALTHCARE MARKET, BY REGION 25
1.3.2 YEARS CONSIDERED 26
1.4 CURRENCY 26
TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 26
1.5 STAKEHOLDERS 27
1.6 LIMITATIONS 27
1.7 IMPACT OF RECESSION 27
2 RESEARCH METHODOLOGY 28
2.1 RESEARCH APPROACH 28
FIGURE 2 RESEARCH DESIGN 28
2.1.1 SECONDARY RESEARCH 29
2.1.1.1 Key data from secondary sources 30
2.1.2 PRIMARY RESEARCH 30
FIGURE 3 PRIMARY SOURCES 31
2.1.2.1 Key data from primary sources 32
2.1.2.2 Breakdown of primaries 32
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 32
2.1.2.3 Insights from primary experts 33
2.2 MARKET SIZE ESTIMATION 33
FIGURE 5 BOTTOM-UP APPROACH 34
FIGURE 6 TOP-DOWN APPROACH 35
FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF DIGITAL TWINS IN HEALTHCARE INDUSTRY 36
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 36
2.3 MARKET BREAKDOWN DATA TRIANGULATION 37
FIGURE 9 DATA TRIANGULATION METHODOLOGY 38
2.4 MARKET SHARE ESTIMATION 38
2.5 STUDY ASSUMPTIONS 39
2.6 RESEARCH LIMITATIONS 39
2.6.1 METHODOLOGY-RELATED LIMITATIONS 39
2.7 RISK ASSESSMENT 40
TABLE 3 RISK ASSESSMENT: DIGITAL TWINS IN HEALTHCARE MARKET 40
2.8 IMPACT OF RECESSION ON DIGITAL TWINS IN HEALTHCARE MARKET 40
3 EXECUTIVE SUMMARY 41
FIGURE 10 DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2023 VS. 2028 (USD MILLION) 41
FIGURE 11 DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 42
FIGURE 12 DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 43
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF DIGITAL TWINS IN HEALTHCARE MARKET 44
4 PREMIUM INSIGHTS 45
4.1 DIGITAL TWINS IN HEALTHCARE MARKET OVERVIEW 45
FIGURE 14 INCREASING USE OF DIGITAL TWINS AND GROWING IMPORTANCE OF PATIENT-CENTRIC CARE IN HEALTHCARE TO DRIVE MARKET GROWTH 45
4.2 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT AND COUNTRY 46
FIGURE 15 SOFTWARE SEGMENT TO COMMAND LARGEST SHARE OF ASIA PACIFIC MARKET IN 2023 46
4.3 GEOGRAPHIC SNAPSHOT OF DIGITAL TWINS IN HEALTHCARE MARKET 47
FIGURE 16 MARKET IN CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 47
4.4 REGIONAL MIX: DIGITAL TWINS IN HEALTHCARE MARKET 48
FIGURE 17 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 48
4.5 DIGITAL TWINS IN HEALTHCARE MARKET: DEVELOPED VS. DEVELOPING ECONOMIES 48
FIGURE 18 DEVELOPING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 48
5 MARKET OVERVIEW 49
5.1 INTRODUCTION 49
5.2 MARKET DYNAMICS 49
FIGURE 19 DIGITAL TWINS IN HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49
TABLE 4 MARKET DYNAMICS: DIGITAL TWINS IN HEALTHCARE MARKET 50
5.2.1 MARKET DRIVERS 50
5.2.1.1 Increasing investments by public and private entities 50
5.2.1.2 Growing applications of digital twins 51
5.2.1.3 Technological advancements 51
5.2.1.4 Growing funding and investments in digital twin start-ups 51
5.2.2 RESTRAINTS 52
5.2.2.1 Managing data quality, privacy issues, and high implementation costs 52
5.2.3 OPPORTUNITIES 52
5.2.3.1 Increasing focus on cutting-edge real-time data analytics 52
5.2.3.2 Growing importance of digital twins in emerging economies 53
5.2.4 CHALLENGES 53
5.2.4.1 Lack of skilled professionals 53
5.2.4.2 Integration with existing systems and outdated digital infrastructure 53
6 INDUSTRY INSIGHTS 54
6.1 INDUSTRY TRENDS 54
6.1.1 TRANSFORMATION IN CLINICAL TRIALS 54
6.1.2 REVOLUTIONIZING MEDICAL TRAINING AND DIAGNOSTICS 54
6.1.3 IMPROVING OPERATIONAL EFFICIENCY IN HOSPITALS 54
6.2 TECHNOLOGY ANALYSIS 55
6.2.1 TECHNOLOGY STACK 55
FIGURE 20 DIGITAL TWIN TECHNOLOGIES 55
6.2.1.1 5G networks 56
6.2.1.2 Internet of Things 56
6.2.1.3 Cloud and edge computing 56
6.2.1.4 Blockchain 57
6.2.1.5 Augmented reality, virtual reality, and mixed reality 57
6.2.1.6 Artificial intelligence and machine learning 58
6.3 PORTER’S FIVE FORCES ANALYSIS 58
FIGURE 21 DIGITAL TWINS IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS 59
TABLE 5 DIGITAL TWINS IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS 59
6.3.1 INTENSITY OF COMPETITIVE RIVALRY 60
6.3.2 BARGAINING POWER OF SUPPLIERS 60
6.3.3 BARGAINING POWER OF BUYERS 60
6.3.4 THREAT OF NEW ENTRANTS 60
6.3.5 THREAT OF SUBSTITUTES 61
6.4 REGULATORY LANDSCAPE 61
6.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 61
TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 61
TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62
TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64
TABLE 9 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65
TABLE 10 DIGITAL TWINS IN HEALTHCARE MARKET: REGULATORY STANDARDS 66
6.5 VALUE CHAIN ANALYSIS 68
FIGURE 22 VALUE CHAIN ANALYSIS (2022) 68
6.5.1 PLANNING & REVISING FUNDS 68
6.5.2 RESEARCH & DEVELOPMENT 68
6.5.3 SOFTWARE DESIGN, FRAMEWORK, AND DEVELOPMENT 69
6.5.4 PRODUCT/SOLUTION PROVIDERS 69
6.5.5 END USERS AND AFTER-SALES SERVICE PROVIDERS 69
6.6 ECOSYSTEM/MARKET MAP 69
FIGURE 23 DIGITAL TWINS IN HEALTHCARE MARKET: ECOSYSTEM 70
6.7 PATENT ANALYSIS 70
FIGURE 24 NUMBER OF PATENTS PUBLISHED, JANUARY 2013 TO MARCH 2023 70
FIGURE 25 TOP PATENT OWNERS IN DIGITAL TWINS IN HEALTHCARE MARKET 71
TABLE 11 KEY PATENTS IN DIGITAL TWINS IN HEALTHCARE MARKET 71
6.8 ADJACENT MARKET ANALYSIS 73
FIGURE 26 METAVERSE IN HEALTHCARE MARKET: MARKET OVERVIEW 73
6.9 CASE STUDY ANALYSIS 74
6.10 KEY STAKEHOLDERS & BUYING CRITERIA 75
6.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 75
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 75
TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 75
6.10.2 BUYING CRITERIA 76
FIGURE 28 KEY BUYING CRITERIA FOR DIGITAL TWIN COMPONENTS 76
TABLE 13 KEY BUYING CRITERIA FOR DIGITAL TWIN COMPONENTS 76
6.11 KEY CONFERENCES & EVENTS, 2023–2024 77
TABLE 14 DIGITAL TWINS IN HEALTHCARE MARKET: DETAILED LIST OF CONFERENCES & EVENTS 77
6.12 TRENDS/DISRUPTIONS IMPACTING BUYERS 77
FIGURE 29 DIGITAL TWINS IN HEALTHCARE MARKET: TRENDS/DISRUPTIONS IMPACTING BUYERS 77
7 DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT 78
7.1 INTRODUCTION 79
TABLE 15 DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 79
7.2 SERVICES 79
7.2.1 INTRODUCTION OF COMPLEX SOFTWARE TO DRIVE DEMAND FOR SERVICES 79
TABLE 16 DIGITAL TWINS IN HEALTHCARE SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 80
7.3 SOFTWARE 81
7.3.1 SHIFT TO WEB/CLOUD-BASED MODELS TO SUPPORT GROWTH 81
TABLE 17 KEY SOFTWARE SOLUTIONS OFFERED BY MARKET PLAYERS 81
TABLE 18 DIGITAL TWINS IN HEALTHCARE SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
8 DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION 83
8.1 INTRODUCTION 84
TABLE 19 DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 84
8.2 DRUG DISCOVERY & DEVELOPMENT 84
8.2.1 ABILITY OF DIGITAL TWINS TO ENHANCE DRUG DISCOVERY & DEVELOPMENT TO BOOST MARKET 84
TABLE 20 DIGITAL TWINS IN HEALTHCARE MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 85
8.3 PERSONALIZED MEDICINE 85
8.3.1 QUICK AND COST-EFFECTIVE DEVELOPMENT AND TESTING OF PERSONALIZED DIAGNOSTICS TO SUPPORT MARKET 85
TABLE 21 DIGITAL TWINS IN HEALTHCARE MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 86
8.4 SURGICAL PLANNING & MEDICAL EDUCATION 87
8.4.1 ABILITY OF DIGITAL TWINS TO ENHANCE SURGICAL TRAINING AND SIMULATE SURGICAL PROCEDURES TO BOOST ADOPTION 87
TABLE 22 DIGITAL TWINS IN HEALTHCARE MARKET FOR SURGICAL PLANNING & MEDICAL EDUCATION, BY COUNTRY, 2021–2028 (USD MILLION) 87
8.5 MEDICAL DEVICE DESIGN & TESTING 88
8.5.1 POTENTIAL OF DIGITAL TWINS TO STREAMLINE OPERATIONS, MINIMIZE RISK, AND REDUCE DOWNTIME TO PROMOTE USE 88
TABLE 23 DIGITAL TWINS IN HEALTHCARE MARKET FOR MEDICAL DEVICE DESIGN & TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 88
8.6 HEALTHCARE WORKFLOW OPTIMIZATION & ASSET MANAGEMENT 89
8.6.1 ADVANTAGES SUCH AS IMPROVED EFFICIENCY AND VALUABLE INSIGHTS TO SUPPORT DEMAND 89
TABLE 24 DIGITAL TWINS IN HEALTHCARE MARKET FOR HEALTHCARE WORKFLOW OPTIMIZATION & ASSET MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION) 89
8.7 OTHER APPLICATIONS 90
TABLE 25 DIGITAL TWINS IN HEALTHCARE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 91
9 DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER 92
9.1 INTRODUCTION 93
TABLE 26 DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 93
9.2 PHARMA & BIOPHARMA COMPANIES 93
9.2.1 RISING DEMAND FOR SOLUTIONS TO REDUCE TIME AND COST OF DRUG DEVELOPMENT TO BOOST ADOPTION 93
TABLE 27 DIGITAL TWINS IN HEALTHCARE MARKET FOR PHARMA & BIOPHARMA COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 94
9.3 RESEARCH & ACADEMIA 94
9.3.1 INTERACTIVE AND IMMERSIVE LEARNING EXPERIENCES OFFERED BY DIGITAL TWINS TO BOOST ADOPTION 94
TABLE 28 DIGITAL TWINS IN HEALTHCARE MARKET FOR RESEARCH & ACADEMIA, BY COUNTRY, 2021–2028 (USD MILLION) 95
9.4 HEALTHCARE PROVIDERS 96
9.4.1 LOWER COSTS AND BETTER PATIENT TREATMENT TO FAVOR MARKET GROWTH 96
TABLE 29 DIGITAL TWINS IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 97
9.5 MEDICAL DEVICE COMPANIES 97
9.5.1 GROWING USE OF DIGITAL TWINS FOR SOFTWARE OPTIMIZATION OF MEDICAL DEVICES TO FUEL GROWTH 97
TABLE 30 DIGITAL TWINS IN HEALTHCARE MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 98
9.6 OTHER END USERS 98
TABLE 31 DIGITAL TWINS IN HEALTHCARE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 99
10 DIGITAL TWINS IN HEALTHCARE MARKET, BY REGION 100
10.1 INTRODUCTION 101
TABLE 32 DIGITAL TWINS IN HEALTHCARE MARKET, BY REGION, 2021–2028 (USD MILLION) 101
10.2 NORTH AMERICA 101
FIGURE 30 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET SNAPSHOT 102
TABLE 33 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 34 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 103
TABLE 35 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 103
TABLE 36 NORTH AMERICA: DIGITAL TWINS IN MARKET, BY END USER, 2021–2028 (USD MILLION) 104
10.2.1 US 104
10.2.1.1 Expanding applications of digital twins in healthcare to bolster market growth 104
TABLE 37 US: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 105
TABLE 38 US: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 105
TABLE 39 US: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 106
10.2.2 CANADA 106
10.2.2.1 Growing investments in digital twin development to drive market 106
TABLE 40 CANADA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 107
TABLE 41 CANADA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 107
TABLE 42 CANADA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 108
10.3 EUROPE 108
TABLE 43 EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 44 EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 109
TABLE 45 EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 110
TABLE 46 EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 110
10.3.1 GERMANY 111
10.3.1.1 Collaborations & partnerships to drive adoption of digital twins 111
TABLE 47 GERMANY: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 111
TABLE 48 GERMANY: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 112
TABLE 49 GERMANY: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 112
10.3.2 UK 113
10.3.2.1 Growing applications of digital twins to support growth 113
TABLE 50 UK: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 113
TABLE 51 UK: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 114
TABLE 52 UK: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 114
10.3.3 FRANCE 115
10.3.3.1 Growing government funding for digital twin development to bolster growth 115
TABLE 53 FRANCE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 115
TABLE 54 FRANCE: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 116
TABLE 55 FRANCE: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 116
10.3.4 REST OF EUROPE 117
TABLE 56 REST OF EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 117
TABLE 57 REST OF EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 118
TABLE 58 REST OF EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 118
10.4 ASIA PACIFIC 119
FIGURE 31 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET SNAPSHOT 120
TABLE 59 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 60 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 121
TABLE 61 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 121
TABLE 62 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 122
10.4.1 JAPAN 122
10.4.1.1 Growing penetration of digital twin technologies to support market growth 122
TABLE 63 JAPAN: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT,
2021–2028 (USD MILLION) 123
TABLE 64 JAPAN: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 123
TABLE 65 JAPAN: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 124
10.4.2 CHINA 124
10.4.2.1 China to register highest CAGR during forecast period 124
TABLE 66 CHINA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 125
TABLE 67 CHINA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 125
TABLE 68 CHINA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 126
10.4.3 REST OF ASIA PACIFIC 126
TABLE 69 REST OF ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 127
TABLE 70 REST OF ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 127
TABLE 71 REST OF ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 128
10.5 REST OF THE WORLD 128
TABLE 72 REST OF THE WORLD: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 129
TABLE 73 REST OF THE WORLD: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 129
TABLE 74 REST OF THE WORLD: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION) 130
11 COMPETITIVE LANDSCAPE 131
11.1 OVERVIEW 131
FIGURE 32 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2020 AND MAY 2023 131
11.2 MARKET RANKING ANALYSIS 132
FIGURE 33 DIGITAL TWINS IN HEALTHCARE MARKET RANKING ANALYSIS, BY PLAYER, 2022 132
11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 132
FIGURE 34 DIGITAL TWINS IN HEALTHCARE MARKET: REVENUE ANALYSIS OF KEY PLAYERS 133
11.4 DIGITAL TWINS IN HEALTHCARE MARKET: R&D EXPENDITURE 133
FIGURE 35 R&D EXPENDITURE OF KEY PLAYERS (2021 VS. 2022) 133
11.5 COMPETITIVE BENCHMARKING 134
TABLE 75 FOOTPRINT OF COMPANIES IN DIGITAL TWINS IN HEALTHCARE MARKET 134
TABLE 76 COMPANY COMPONENT FOOTPRINT (20 COMPANIES) 135
TABLE 77 COMPANY APPLICATION FOOTPRINT (20 COMPANIES) 136
TABLE 78 COMPANY REGIONAL FOOTPRINT (20 COMPANIES) 137
11.6 COMPANY EVALUATION QUADRANT 138
11.6.1 STARS 138
11.6.2 EMERGING LEADERS 138
11.6.3 PERVASIVE PLAYERS 138
11.6.4 PARTICIPANTS 139
FIGURE 36 DIGITAL TWINS IN HEALTHCARE MARKET: COMPANY EVALUATION QUADRANT (2022) 139
11.7 COMPANY EVALUATION MATRIX FOR START-UPS/SMES 140
11.7.1 PROGRESSIVE COMPANIES 140
11.7.2 DYNAMIC COMPANIES 140
11.7.3 RESPONSIVE COMPANIES 140
11.7.4 STARTING BLOCKS 140
FIGURE 37 DIGITAL TWINS IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022) 141
11.8 COMPETITIVE SCENARIO 142
11.8.1 PRODUCT/SERVICE LAUNCHES & APPROVALS 142
TABLE 79 PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2020– MAY 2023 142
11.8.2 DEALS 143
TABLE 80 DEALS, JANUARY 2020– MAY 2023 143
12 COMPANY PROFILES 144
12.1 KEY PLAYERS 144
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 MICROSOFT 144
TABLE 81 MICROSOFT: BUSINESS OVERVIEW 144
FIGURE 38 MICROSOFT: COMPANY SNAPSHOT (2022) 145
12.1.2 SIEMENS HEALTHINEERS AG 148
TABLE 82 SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW 148
FIGURE 39 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2022) 149
12.1.3 KONINKLIJKE PHILIPS N.V. 152
TABLE 83 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 152
FIGURE 40 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022) 153
12.1.4 AMAZON (AWS) 155
TABLE 84 AMAZON: BUSINESS OVERVIEW 155
FIGURE 41 AMAZON: COMPANY SNAPSHOT (2022) 156
12.1.5 DASSAULT SYSTÈMES 159
TABLE 85 DASSAULT SYSTÈMES: BUSINESS OVERVIEW 159
FIGURE 42 DASSAULT SYSTÈMES: COMPANY SNAPSHOT (2022) 160
12.1.6 GE HEALTHCARE 163
TABLE 86 GE HEALTHCARE: BUSINESS OVERVIEW 163
FIGURE 43 GE HEALTHCARE: COMPANY SNAPSHOT (2022) 164
12.1.7 ORACLE 166
TABLE 87 ORACLE: BUSINESS OVERVIEW 166
FIGURE 44 ORACLE: COMPANY SNAPSHOT (2022) 167
12.1.8 IBM 170
TABLE 88 IBM: BUSINESS OVERVIEW 170
FIGURE 45 IBM: COMPANY SNAPSHOT (2022) 171
12.1.9 PTC 173
TABLE 89 PTC: BUSINESS OVERVIEW 173
FIGURE 46 PTC: COMPANY SNAPSHOT (2022) 174
12.1.10 SAP 176
TABLE 90 SAP: BUSINESS OVERVIEW 176
FIGURE 47 SAP: COMPANY SNAPSHOT (2022) 177
12.1.11 ATOS SE 179
TABLE 91 ATOS SE: BUSINESS OVERVIEW 179
FIGURE 48 ATOS SE: COMPANY SNAPSHOT (2022) 179
12.1.12 NVIDIA CORPORATION 181
TABLE 92 NVIDIA CORPORATION: BUSINESS OVERVIEW 181
FIGURE 49 NVIDIA CORPORATION: COMPANY SNAPSHOT (2022) 182
12.1.13 ANSYS INC. 185
TABLE 93 ANSYS INC.: BUSINESS OVERVIEW 185
FIGURE 50 ANSYS INC.: COMPANY SNAPSHOT (2022) 186
12.1.14 FASTSTREAM TECHNOLOGIES 189
TABLE 94 FASTSTREAM TECHNOLOGIES: BUSINESS OVERVIEW 189
12.1.15 RESCALE, INC. 190
TABLE 95 RESCALE, INC.: BUSINESS OVERVIEW 190
12.2 OTHER PLAYERS 192
12.2.1 TWIN LTD. 192
TABLE 96 TWIN LTD.: BUSINESS OVERVIEW 192
12.2.2 VERTO HEALTH 194
TABLE 97 VERTO HEALTH: BUSINESS OVERVIEW 194
12.2.3 QBIO 196
TABLE 98 QBIO: BUSINESS OVERVIEW 196
12.2.4 THOUGHTWIRE 197
TABLE 99 THOUGHTWIRE: BUSINESS OVERVIEW 197
12.2.5 SIM AND CURE 198
TABLE 100 SIM AND CURE: BUSINESS OVERVIEW 198
12.2.6 PREDICTIV 199
TABLE 101 PREDICTIV: BUSINESS OVERVIEW 199
12.2.7 NUREA 200
TABLE 102 NUREA: BUSINESS OVERVIEW 200
12.2.8 UNLEARN.AI 201
TABLE 103 UNLEARN.AI: BUSINESS OVERVIEW 201
12.2.9 VIRTONOMY GMBH 202
TABLE 104 VIRTONOMY GMBH: BUSINESS OVERVIEW 202
12.2.10 PREDISURGE 203
TABLE 105 PREDISURGE: BUSINESS OVERVIEW 203
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 204
13.1 DISCUSSION GUIDE 204
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 208
13.3 CUSTOMIZATION OPTIONS 210
13.4 RELATED REPORTS 211
13.5 AUTHOR DETAILS 212
